Myomo (MYO) Cash & Equivalents (2016 - 2025)

Myomo's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $14.7 million for Q4 2025.

• Quarterly Cash & Equivalents fell 40.57% year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (down 40.57% YoY) and the FY2025 annual result came in at $14.7 million, down 40.57% from the prior year.
• Cash & Equivalents was $14.7 million for Q4 2025 at Myomo, up from $12.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $24.7 million in Q4 2024 and bottomed at $5.3 million in Q4 2022.
• A 5-year average of $11.5 million and a median of $11.4 million in 2021 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 65.56% — and 2025, when it soared 271.11%.
• Myomo's Cash & Equivalents stood at $15.5 million in 2021, then slumped by 65.56% to $5.3 million in 2022, then increased by 28.53% to $6.9 million in 2023, then soared by 260.16% to $24.7 million in 2024, then tumbled by 40.57% to $14.7 million in 2025.
• Business Quant data shows MYO's Cash & Equivalents at $14.7 million in Q4 2025, $12.9 million in Q3 2025, and $14.6 million in Q2 2025.